Entering text into the input field will update the search result below
Search for Symbols, analysts, keywords

Wide-Moat Stocks On Sale - The August 2022 Heat Map

Aug. 01, 2022 2:43 PM ETBABA, BAYRY, CMCSA, CRM, ETSY, GILD, IMBBF, IMBBY, MELI, META, NOW, RHHBF, RHHBY, TCEHY, TRU, TSM, WU3 Comments
The FALCON Method profile picture
The FALCON Method
12.48K Followers

Summary

  • Our 3-step process focuses on wide-moat stocks (as per Morningstar’s rating).
  • We are only interested in those targets that are attractively valued in historical comparison.
  • We share the heat map of the most investable candidates that may be worth your time for further analysis.

Bodiam Castle in England

ValeryEgorov

Step One: Wide-moat stocks with 5-star and 4-star ratings

Historical evidence says that while quality alone is a poor indicator of outperformance, when combined with a decent valuation filter, Morningstar’s moat rating proves to be more than useful. Based on the

This article was written by

The FALCON Method profile picture
The FALCON Method
12.48K Followers
The FALCON Method is a monthly newsletter service, resting on an evidence-based stock selection process that serves the construction of a buy and hold portfolio with both an income and total return focus. All the elements of the FALCON Method are proven to support outperformance and combining them further increases the odds of achieving outstanding results. We conduct our research in the shareholder-value-focused EVA (Economic Value Added) framework, and provide exclusive content to our Seeking Alpha readers with a pronounced focus on quality compounders or "EVA Monsters".

Analyst’s Disclosure: I/we have a beneficial long position in the shares of BLK, BRK.B, META, BABA, TCEHY, TROW, MMM, GOOGL, SBUX, AMZN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

Comments (3)

d
david8fu
02 Aug. 2022
Comments (93)
How come GILD, with one of the best scores both in quality and valuation, has performed so poorly in one,five and ten years?
m
mkgolden
06 Aug. 2022
Premium
Comments (642)
@david8fu they made the mistake of actually curing Hep C. I owned them for a while but they just never go anywhere.
BM Cashflow Detective profile picture
BM Cashflow Detective
02 Aug. 2022
PremiumInvesting Group
Comments (7.44K)
The $IMBBV with a PRVit score of 85.8 is somehow a surprise.

Due to a closer look at most of the metrics, it is somewhat difficult to trace the supposed fundamental strength and in fact it is hardly comprehensible.

It can actually only be explained by the enormous undervaluation by the undervaluation score of 30.2.

A supposed weakness of non-transparent quantitative classifications.

Also surprising is that $BTI is not found in the list. One of the current biggest offers. Very pity.

But otherwise the rest seems plausible.
Disagree with this article? Submit your own. To report a factual error in this article, . Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.